Oncologists Accepting Blue Cross and Blue Shield of MassachusettsPage 7

Zofia Piotrowska, MD

Associate Professor of Medicine, Harvard Medical School

Oncology

Taylor Ortiz, MD

Director, Dana-Farber – Merrimack Valley

Oncology

Charlene Mantia, M.D.

Instructor in Medicine, Harvard Medical School

Oncology

Payal Gupta, MD

Oncology

Genevieve Boland, MD, PHD

Vice Chair of Research, Department of Surgery; Director, Therapeutic Intralesional Program; Surgical Director, Termeer Center for Targeted Therapies; Associate Professor, Harvard Medical School

Oncology

Othon Iliopoulos, MD

Oncology

Ritu Gill, MD

Professor of Radiology; Chief, Division of Cardiothoracic Imaging

Oncology

Martha Wadleigh, MD

Director, Inpatient Oncology; Assistant Professor of Medicine, Harvard Medical School

Oncology

George Molina, MD, MPH

Oncology

Raul Uppot, MD

Chief of Interventional Radiology, Academic Medical Centers, Mass General Brigham; Associate Professor of Radiology, Harvard Medical School; Director, Abdominal Imaging Fellowship, Massachusetts General Hospital; Executive Director, Mass General Brigham Medical Extended Reality Lab

Oncology

Otto Metzger, M.D.

Director, International Strategic Initiatives; Assistant Professor of Medicine, Harvard Medical School

Oncology

Rochelle Scheib, MD

Professor of Medicine, Harvard Medical School

Oncology

Matthew Oser, M.D./PH.D.

Assistant Professor of Medicine at Dana-Farber Cancer Institute and Harvard Medical School where he runs a research laboratory focused on small cell lung cancer and is a; Associate Professor of Medicine, Harvard Medical School

Oncology

Rizwan Haq, MD, PHD

Assistant Professor, Harvard Medical School

Oncology

Shayna Sarosiek, MD

Senior Physician; Assistant Professor of Medicine, Harvard Medical School

Oncology

Ting Bao, M.D.

Director of the Zakim Center for Integrative Therapies and Healthy Living at the Dana-Farber Cancer Institute. She was a joint faculty member at Memoria

Oncology

Amy Bregar, MD

Assistant Professor of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School

Oncology

David Jackman, M.D.

Director for Clinical Pathways and New Business Initiatives. His research interests include targeted therapies in lung cancer and mesothelioma, and canc; Senior Physician

Oncology

Laura Spring, M.D.

Assistant Professor of Medicine, Harvard Medical School

Oncology

Arielle Langer, MD, MPH

Instructor in Medicine, Harvard Medical School; Assistant Professor of Medicine, Brigham and Women's Hospital

Oncology